Meeting
2018 ASCO Annual Meeting
A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.
Authors
Shuchi Gulati
University of Cincinnati Medical Center, Cincinnati, OH
Shuchi Gulati , Benyamin Yaniv , Sarah Palackdharry , Vinita Takiar , Michelle Lynn Mierzwa , Muhammad Kashif Riaz , John Charles Morris , Changchun Xie , J. Silvio Gutkind , Pankaj B Desai , Nooshin Hashemi Sadraei , Trisha Michel Wise-Draper
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02325401
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6074)
DOI
10.1200/JCO.2018.36.15_suppl.6074
Abstract #
6074
Poster Bd #
62
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Combination of nivolumab with chemoradiotherapy for locally advanced cervical cancer: NiCOL phase I trial.
First Author: Manuel Rodrigues
Poster
2020 ASCO Virtual Scientific Program
Base excision repair (BER) inhibitor TRC 102 (Methoxyamine) combined with pemetrexed (PEM)-based chemo-radiation (CRT) for locally advanced non-squamous non-small cell lung cancer (NS-NSCLC): Results of a phase I trial.
First Author: Tithi Biswas
Poster
2017 ASCO Annual Meeting
A phase I study of sequential ipilimumab in the definitive treatment of node positive cervical cancer: GOG 9929.
First Author: Jyoti Mayadev
Poster
2016 ASCO Annual Meeting
A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.
First Author: Trisha Michel Wise-Draper